Xience V
Payments companies reported to CMS as associated with Xience V. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xience V, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xience V
These are the largest totals companies reported as associated with Xience V. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Marx | New York, NY | Cardiovascular Disease | $63,316.00 |
| Ozgen Dogan | Brooklyn, NY | Cardiovascular Disease | $54,066.00 |
| Daniel Asemota | Los Angeles, CA | Interventional Cardiology | $45,182.00 |
| Monika Karki | Fort Lauderdale, FL | Internal Medicine | $30,000.00 |
| Caleb Wutawunashe | New York, NY | $27,273.00 | |
| Fahad Gul | New York, NY | Interventional Cardiology | $27,273.00 |
| Samantha Espinosa | Boston, MA | Cardiovascular Disease | $27,000.00 |
| Rene Boudreau | Boston, MA | $27,000.00 | |
| Sorin Brener | Brooklyn, NY | Interventional Cardiology | $23,066.00 |
| Mark Connolly | Paterson, NJ | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $20,250.00 |
Prescribed Xience V?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.